Profilo
Mark T.
Marino held several positions in the pharmaceutical industry, including Senior VP-Research & Clinical Operations at MannKind Corp., Head-Clinical Pharmacology at Eisai, Inc., Vice President at Daiichi Sankyo, Inc., and Chief Medical Officer at Imugene Ltd.
He also worked as an Associate Professor at the Uniformed Services University of the Health Sciences and Head-Pharmacology at the Walter Reed Army Institute of Research.
Marino received his undergraduate degree from the US Military Academy and his doctorate from Albert Einstein College of Medicine, Inc.
Precedenti posizioni note di Mark T. Marino
| Società | Posizione | Fine |
|---|---|---|
| IMUGENE LIMITED | Direttore Tecnico/Scientifico/R&S | 30/09/2020 |
| Walter Reed Army Institute of Research | Corporate Officer/Principal | - |
| Uniformed Services University of the Health Sciences | Corporate Officer/Principal | - |
| Roche Corp. | Corporate Officer/Principal | - |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Corporate Officer/Principal | - |
Formazione di Mark T. Marino
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
| US Military Academy | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| PLUS THERAPEUTICS, INC. | Health Technology |
| MANNKIND CORPORATION | Health Technology |
| IMUGENE LIMITED | Health Technology |
| Aziende private | 4 |
|---|---|
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
| Roche Corp. | |
| Walter Reed Army Institute of Research |
- Borsa valori
- Insiders
- Mark T. Marino
